Inpharma Weekly

, Volume 1416, Issue 1, pp 3–3 | Cite as

Sketchy evidence supports use of mitoxantrone in MS

Review

Keywords

Adverse Effect Clinical Trial Multiple Sclerosis Clinical Benefit Chemotherapeutic Agent 

Copyright information

© Adis International Ltd 2003

Personalised recommendations